Purpose: Hereditary hemorrhagic telangiectasia is an autosomal dominant disorder characterized by arteriovenous malformations (AVM), mostly cutaneous and mucous (telangiectases), but also ...
The second patient was a 30 year old woman who had three episodes of paroxysmal left lip movement 4 weeks after child delivery; MRI showed capillary telangiectasia in the right corticonuclear pathway.
Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce the successful ...
Levacetylleucine is under clinical development by IntraBio and currently in Phase II for Ataxia-Telangiectasia (Louis-Bar Syndrome). According to GlobalData, Phase II drugs for Ataxia-Telangiectasia ...